A double prodrug system for colon targeting of benzenesulfonamide COX-2 inhibitors |
| |
Authors: | Ruiz Juan F Marquez Kedziora Kinga Keogh Brian Maguire Jacqueline Reilly Mary Windle Henry Kelleher Dermot P Gilmer John F |
| |
Institution: | School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin 2, Ireland. |
| |
Abstract: | The design, synthesis and delivery potential of a new type of benzenesulfonamide cyclo-oxygenase-2 (COX-2) inhibitor prodrug is investigated using celecoxib. The approach involves a double prodrug that is activated first by azoreductases and then by cyclization triggering drug release. We studied the intramolecular aminolysis of the acylsulfonamide. The cyclization was surprisingly rapid at physiological pH and very fast at pH 5. The prodrug is activated specifically under conditions found in the colon but highly stable in the presence of human and rodent intestinal extracts. Finally, the prototype with celecoxib was transported much more slowly in the Caco-2 transepithelial model than the parent. The design therefore shows significant promise for the site specific delivery of benzenesulfonamide COX-2 inhibitors to the colon. |
| |
Keywords: | COX-2 inhibitor Colon cancer Celecoxib Azoreductase Cyclization |
本文献已被 ScienceDirect PubMed 等数据库收录! |